Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6402 posts found.

Biogen’s Aduhelm shown to reduce clinical decline in Alzheimer’s disease

November 12, 2021 Medical Communications

New ADUHELM (aducanumab-avwa) Phase III data has shown a positive correlation between plasma p-tau reduction and less cognitive and functional …
News

Blood pressure drugs could protect against type 2 diabetes

November 12, 2021 Medical Communications

Researchers have found that blood pressure drugs may directly reduce people’s risk of type 2 diabetes, a condition that an …
News
mat-napo-pij34zrzeew-unsplash

Trial investigates whether immunosuppressant holiday boosts vaccine protection

November 12, 2021 Medical Communications

A trial has been launched to evaluate how to increase COVID-19 vaccine protection among vulnerable patients taking immunosuppressant drugs . …
News

Kintor Pharma begins Phase II trial of KX-826 for androgenetic alopecia treatment

November 12, 2021 Medical Communications

Kintor Pharma, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced that the company has dosed the …
News

BIAL appoints Joerg Holenz as R&D General Manager

November 8, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Bial, appointments

BIAL have announced the appointment of Jorg Holenz as R&D General Manager, replacing Patricio da Silva, who steps down after …
Appointment

FDA decline Emergency Use Authorisation for ZYESAMI® in patients with critical COVID

November 5, 2021 Medical Communications

The FDA has declined to grant Emergency Use Authorisation for NRx Pharmaceuticals’ therapy, Zyesami® (aviptadil), in the treatment of critical …
News
credit_-_crevis_shutterstock_340710245_720

Pfizer and Entia’s breast cancer home test in final stages

November 5, 2021 Medical Communications

Pfizer UK and Entia’s home blood monitoring device for breast cancer patients is in late-stage development, with regulatory approvals expected …
News

Republicans governors retaliate against Biden vaccine mandate

November 5, 2021 Medical Communications

Republican governors are expected to sue in response to the Biden administration’s requirement that US employers ensure workers are tested …
News

Scientists identify new drug combination for children with brain cancer

November 5, 2021 Medical Communications

A new study has shown that combining two existing cancer drugs for leukaemia and melanoma could offer a promising future …
News
kjm_cropped

HMNC Brain Health appoints Dr Katarina Jelic Maiboe Head of Regulatory Affairs

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing HMNC Brain Health, appointments

HMNC Brain Health, a clinical-stage biopharma company pioneering the development of personalised therapies powered by predictive companion diagnostics, today announced …
Appointment

Outsourcing in clinical trials: A response to rising challenges

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

The pandemic has undoubtedly had a detrimental impact on the pharmaceutical and healthcare industries. Brexit has rubbed salt in the …
Feature

Risking it all after the pandemic: How companies can pick up the slack post-COVID-19

November 3, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Pharmaceutical manufacturers have always been tasked with some of the most complex remits in the industry. Active pharmaceutical ingredients, potent …
Feature
beverley-carr-enhanced

Beverley Carr appointed Chief Business Officer for Amphista Therapeutics

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing amphista, appointments

Amphista Therapeutics have appointed Beverley Carr Chief Business Officer. Amphista is a leader in next generation targeted protein degradation (TPD) …
Appointment

Mogrify appoint Tom Graney Non-Executive Director, Audit Chair and Capital Markets Advisor

November 2, 2021 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing appointments, mogrify

Mogrify Limited have announced the appointment of Tom Graney, CFA as Non-Executive Director, Audit Chair and Capital Markets Advisor. He …
Appointment

Gilead collaborate with Merck for first-line triple negative breast cancer trial

October 29, 2021 Medical Communications

Gilead Sciences announced that it has entered into a clinical trial collaboration and supply agreement with MSD (known as Merck …
News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025